Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Adicionar filtros








Intervalo de ano
1.
Braz. j. med. biol. res ; 39(11): 1455-1463, Nov. 2006. graf, tab
Artigo em Inglês | LILACS | ID: lil-437835

RESUMO

Experimental models of sepsis-induced pulmonary alterations are important for the study of pathogenesis and for potential intervention therapies. The objective of the present study was to characterize lung dysfunction (low PaO2 and high PaCO2, and increased cellular infiltration, protein extravasation, and malondialdehyde (MDA) production assessed in bronchoalveolar lavage) in a sepsis model consisting of intraperitoneal (ip) injection of Escherichia coli and the protective effects of pentoxifylline (PTX). Male Wistar rats (weighing between 270 and 350 g) were injected ip with 10(7) or 10(9) CFU/100 g body weight or saline and samples were collected 2, 6, 12, and 24 h later (N = 5 each group). PaO2, PaCO2 and pH were measured in blood, and cellular influx, protein extravasation and MDA concentration were measured in bronchoalveolar lavage. In a second set of experiments either PTX or saline was administered 1 h prior to E. coli ip injection (N = 5 each group) and the animals were observed for 6 h. Injection of 10(7) or 10(9) CFU/100 g body weight of E. coli induced acidosis, hypoxemia, and hypercapnia. An increased (P < 0.05) cell influx was observed in bronchoalveolar lavage, with a predominance of neutrophils. Total protein and MDA concentrations were also higher (P < 0.05) in the septic groups compared to control. A higher tumor necrosis factor-alpha (P < 0.05) concentration was also found in these animals. Changes in all parameters were more pronounced with the higher bacterial inoculum. PTX administered prior to sepsis reduced (P < 0.05) most functional alterations. These data show that an E. coli ip inoculum is a good model for the induction of lung dysfunction in sepsis, and suitable for studies of therapeutic interventions.


Assuntos
Animais , Masculino , Ratos , Pneumopatias/tratamento farmacológico , Pentoxifilina/uso terapêutico , Inibidores de Fosfodiesterase/uso terapêutico , Troca Gasosa Pulmonar/efeitos dos fármacos , Sepse/tratamento farmacológico , Doença Aguda , Modelos Animais de Doenças , Infecções por Escherichia coli/complicações , Infecções por Escherichia coli/tratamento farmacológico , Mediadores da Inflamação/sangue , Inflamação/tratamento farmacológico , Malondialdeído/sangue , Ratos Wistar , Sepse/microbiologia
3.
Braz. j. med. biol. res ; 36(10): 1409-1417, Oct. 2003. ilus, tab
Artigo em Inglês | LILACS | ID: lil-346503

RESUMO

Abnormal riboflavin status in the absence of a dietary deficiency was detected in 31 consecutive outpatients with Parkinson's disease (PD), while the classical determinants of homocysteine levels (B6, folic acid, and B12) were usually within normal limits. In contrast, only 3 of 10 consecutive outpatients with dementia without previous stroke had abnormal riboflavin status. The data for 12 patients who did not complete 6 months of therapy or did not comply with the proposed treatment paradigm were excluded from analysis. Nineteen PD patients (8 males and 11 females, mean age ± SD = 66.2 ± 8.6 years; 3, 3, 2, 5, and 6 patients in Hoehn and Yahr stages I to V) received riboflavin orally (30 mg every 8 h) plus their usual symptomatic medications and all red meat was eliminated from their diet. After 1 month the riboflavin status of the patients was normalized from 106.4 ± 34.9 to 179.2 ± 23 ng/ml (N = 9). Motor capacity was measured by a modification of the scoring system of Hoehn and Yahr, which reports motor capacity as percent. All 19 patients who completed 6 months of treatment showed improved motor capacity during the first three months and most reached a plateau while 5/19 continued to improve in the 3- to 6-month interval. Their average motor capacity increased from 44 to 71 percent after 6 months, increasing significantly every month compared with their own pretreatment status (P < 0.001, Wilcoxon signed rank test). Discontinuation of riboflavin for several days did not impair motor capacity and yellowish urine was the only side effect observed. The data show that the proposed treatment improves the clinical condition of PD patients. Riboflavin-sensitive mechanisms involved in PD may include glutathione depletion, cumulative mitochondrial DNA mutations, disturbed mitochondrial protein complexes, and abnormal iron metabolism. More studies are required to identify the mechanisms involved


Assuntos
Humanos , Feminino , Idoso , Masculino , Homocisteína , Doença de Parkinson , Riboflavina , Doença de Parkinson , Deficiência de Riboflavina , Resultado do Tratamento
4.
Braz. j. med. biol. res ; 23(2): 105-11, 1990. ilus, tab
Artigo em Inglês | LILACS | ID: lil-85147

RESUMO

As the first part of a study of pesticide toxicity we report the effects of the solvent dimethylsulfoxide (DMSO) on signal transduction in mutants of Saccharomyces cerevisiae. The enzymes of trehalose metabolism, which are activated and deactivated by a "glucose signal" and by heat shock treatment, were chosen as targets for this study. DMSO was shown to be able to permeate glucose and cAMP. The effects of glucose and cAMP were enhanced by pre-incubating the cells in the presence of DMSO. No effects were observed during the heat shock, suggesting that the solvent acts on the cell membrane. The results suggest that DMSO may be used as a vehicle for small molecules which do not easily penetrate yeast cell membranes, thus providing a new tool for biochemical and toxicological studies


Assuntos
Dimetil Sulfóxido/farmacologia , Glucose/metabolismo , Mutação/genética , Saccharomyces cerevisiae/genética , Transdução de Sinais , Trealose/metabolismo , AMP Cíclico/metabolismo , Ativação Enzimática , Temperatura Alta
6.
An. farm. quím. Säo Paulo ; 22(1/2): 11-7, 1982.
Artigo em Português | LILACS | ID: lil-12461

RESUMO

Foi estudada a atividade de fosfatases acida e alcalina de rim e figado de ratos, tratados por 60 e 90 dias com 900 ppm de hexaclorociclohexano tecnico. Verificou-se uma diminuicao de 46% e 32% na atividade da fosfatase alcalina, respectivamente de figado e rim, apos 60 dias de tratamento com hexaclorociclohexano, sendo que apos 90 dias, a diminuicao dessa atividade e de 37% e 40%, em relacao aos controles. Nao se observou na atividade de fosfatose acida de figado e rim


Assuntos
Masculino , Animais , Ratos , Fosfatase Ácida , Fosfatase Alcalina , Hexaclorocicloexano , Intoxicação , Rim , Fígado
7.
An. farm. quím. Säo Paulo ; 22(1/2): 35-41, 1982.
Artigo em Português | LILACS | ID: lil-12464

RESUMO

Ratos Wistar machos, com 30 dias de idade, foram submetidos a intoxicacao experimental, com 100 ppm de HgCl2, por via oral.Os niveis de lipoperoxidacao hepatica e renal foram avaliados, medindo-se a quantidade total de malonildialdeido (MDA) produzido por homogenados desses orgaos. Nao se obteve nenhuma alteracao na quantidade de MDA produzida pelos homogenados. Cortes histologicos desses orgaos, nos animais tratados, nao mostraram alteracoes, quando comparados com os do grupo controle


Assuntos
Masculino , Animais , Ratos , Rim , Peróxidos Lipídicos , Fígado , Malondialdeído , Intoxicação por Mercúrio
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA